InvestSMART

Mayne Pharma Group Limited (ASX: MYX) - Announcements

Current share price for MYX : $2.660 0.09 (3.27%)+

ASX company news and announcements for Mayne Pharma Group Limited (MYX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Mayne Pharma Group Limited (MYX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Mayne Pharma Group Limited (MYX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Mayne Pharma Group Limited (MYX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$218 Mayne Pharma to present at ASX SMIDcaps Conference 17 Mar 2026 9:00AM $2.320 $2.660 risen by 14.66%
$218 DistributeRx Launch Investor Presentation 11 Mar 2026 9:22AM $2.470 $2.660 risen by 7.69%
$218 Mayne Pharma launches DistributeRx in the US 10 Mar 2026 10:05AM $2.360 $2.660 risen by 12.71%
$218 Becoming a substantial holder 9 Mar 2026 6:01PM $2.340 $2.660 risen by 13.68%
$218 S&P DJI Announces March 2026 Quarterly Rebalance 6 Mar 2026 5:05PM $2.540 $2.660 risen by 4.72%
$218 Becoming a substantial holder 3 Mar 2026 8:26AM $2.450 $2.660 risen by 8.57%
$218 Ceasing to be a substantial holder from MUFG 2 Mar 2026 6:40PM $2.450 $2.660 risen by 8.57%
$218 Final Director's Interest Notice (x2) 2 Mar 2026 2:39PM $2.465 $2.660 risen by 7.91%
$218 Ceasing to be a substantial holder 27 Feb 2026 5:56PM $2.520 $2.660 risen by 5.56%
$218 Proposed issue of securities - MYX 23 Feb 2026 6:56PM $2.610 $2.660 risen by 1.92%
$218 Final Director's Interest Notice 23 Feb 2026 6:51PM $2.610 $2.660 risen by 1.92%
$218 2026 Half Year Investor Presentation 23 Feb 2026 9:38AM $2.650 $2.660 risen by 0.38%
$218 2026 Half Year Media Release 23 Feb 2026 9:35AM $2.650 $2.660 risen by 0.38%
$218 Half Yearly Report and Accounts 23 Feb 2026 9:34AM $2.650 $2.660 risen by 0.38%
$218 Mayne Pharma Management Changes 23 Feb 2026 9:31AM $2.650 $2.660 risen by 0.38%
$218 Notification of date for release of 1H26 results 19 Feb 2026 2:03PM $2.645 $2.660 risen by 0.57%
$218 MYX to claim against Cosette, Avista & Mr David Burgstahler 18 Feb 2026 9:35AM $2.650 $2.660 risen by 0.38%
$218 Ceasing to be a substantial holder 6 Feb 2026 8:18AM $2.700 $2.660 fallen by 1.48%
$218 2025 AGM Results of Meeting 29 Jan 2026 12:09PM $2.820 $2.660 fallen by 5.67%
$218 2025 AGM presentation and business update 29 Jan 2026 9:42AM $2.800 $2.660 fallen by 5%
$218 2025 AGM Chair's Address to Shareholders 29 Jan 2026 9:41AM $2.800 $2.660 fallen by 5%
$218 Ceasing to be a substantial holder 19 Jan 2026 7:48PM $2.890 $2.660 fallen by 7.96%
$218 Change in substantial holding 19 Jan 2026 9:46AM $2.840 $2.660 fallen by 6.34%
$218 Notice of appeal 15 Jan 2026 3:55PM $2.910 $2.660 fallen by 8.59%
$218 Final Director's Interest Notice 14 Jan 2026 9:04AM $3.010 $2.660 fallen by 11.63%

51 - 75 of 904 results

Page 3 of 37

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.